These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 12207741
1. Aberrant expression of p16 and RB protein in eccrine porocarcinoma. Gu LH, Ichiki Y, Kitajima Y. J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741 [Abstract] [Full Text] [Related]
2. Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma. Zahn J, Chan MP, Wang G, Patel RM, Andea AA, Bresler SC, Harms PW. J Cutan Pathol; 2019 Sep; 46(9):659-664. PubMed ID: 31012122 [Abstract] [Full Text] [Related]
3. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study. Tateyama H, Eimoto T, Tada T, Inagaki H, Nakamura T, Yamauchi R. Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450 [Abstract] [Full Text] [Related]
4. P53 protein expression in eccrine poroma and porocarcinoma. Akalin T, Sen S, Yücetürk A, Kandiloğlu G. Am J Dermatopathol; 2001 Oct; 23(5):402-6. PubMed ID: 11801771 [Abstract] [Full Text] [Related]
5. Intracranial extension of an eccrine porocarcinoma. Case report and review of the literature. Ritter AM, Graham RS, Amaker B, Broaddus WC, Young HF. J Neurosurg; 1999 Jan; 90(1):138-40. PubMed ID: 10413167 [Abstract] [Full Text] [Related]
6. Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases. Wittenberg GP, Robertson DB, Solomon AR, Washington CV. Dermatol Surg; 1999 Nov; 25(11):911-3. PubMed ID: 10594609 [Abstract] [Full Text] [Related]
7. Eccrine porocarcinoma with Bowenoid changes: epithelial membrane antigen is not a useful marker for malignant tumours arising from eccrine gland structures. Mariko O, Sotoh T, Yokozeki H, Nishioka K. Acta Derm Venereol; 2004 Nov; 84(2):142-4. PubMed ID: 15206695 [Abstract] [Full Text] [Related]
8. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors? Wollina U, Castelli E, Rülke D. Recent Results Cancer Res; 1995 Nov; 139():303-16. PubMed ID: 7541147 [Abstract] [Full Text] [Related]
9. Eccrine porocarcinoma: a case report. Vandeweyer E, Renorte C, Musette S, Gilles A. Acta Chir Belg; 2006 Nov; 106(1):121-3. PubMed ID: 16612934 [Abstract] [Full Text] [Related]
10. Eccrine porocarcinoma of the upper eyelid. Jain R, Prabhakaran VC, Huilgol SC, Gehling N, James CL, Selva D. Ophthalmic Plast Reconstr Surg; 2008 Nov; 24(3):221-3. PubMed ID: 18520840 [Abstract] [Full Text] [Related]
11. Clear-cell porocarcinoma in situ: a cytologic variant of porocarcinoma in situ. Rutten A, Requena L, Requena C. Am J Dermatopathol; 2002 Feb; 24(1):67-71. PubMed ID: 11803286 [Abstract] [Full Text] [Related]
13. Porocarcinoma of the heel. A case report with unusual histologic features. D'Amato MS, Patterson RH, Guccion JG, White JC, Krasnow SH. Cancer; 1996 Aug 15; 78(4):751-7. PubMed ID: 8756368 [Abstract] [Full Text] [Related]
14. Poroma: a review of eccrine, apocrine, and malignant forms. Sawaya JL, Khachemoune A. Int J Dermatol; 2014 Sep 15; 53(9):1053-61. PubMed ID: 24697501 [Abstract] [Full Text] [Related]
15. Eccrine carcinoma (nodular porocarcinoma) of the vulva. Liegl B, Regauer S. Histopathology; 2005 Sep 15; 47(3):324-6. PubMed ID: 16115237 [No Abstract] [Full Text] [Related]
18. A case of multiple eccrine porocarcinoma with stepping-stone distribution on the foot. Ujihara M, Hamanaka S, Hamanaka Y, Kamei T. J Dermatol; 1995 Jun 27; 22(6):450-7. PubMed ID: 7650246 [Abstract] [Full Text] [Related]
19. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas. Bosic M, Kirchner M, Brasanac D, Leichsenring J, Lier A, Volckmar AL, Oliveira C, Buchhalter I, Stögbauer F, Zivkovic-Perisic S, Goeppert B, Schirmacher P, Penzel R, Endris V, Stenzinger A. Pathology; 2018 Apr 27; 50(3):327-332. PubMed ID: 29269125 [Abstract] [Full Text] [Related]
20. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma. Goto K, Takai T, Fukumoto T, Anan T, Kimura T, Ansai S, Oshitani Y, Murata Y, Sakuma T, Hirose T. J Cutan Pathol; 2016 Mar 27; 43(3):219-26. PubMed ID: 26449497 [Abstract] [Full Text] [Related] Page: [Next] [New Search]